カテゴリ： MarketLine, インド, 企業調査

LIC of India：企業の戦略・SWOT・財務情報

◆英語タイトル：LIC of India - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA904C3929
◆発行会社（調査会社）：MarketLine
◆発行日：2018年8月
◆ページ数：39
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：インド
◆産業分野：サービス
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

LIC of India – Strategy, SWOT and Corporate Finance Report
Summary

LIC of India – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

The Life Insurance Corporation of India (LIC or ‘the company’) is primarily involved in providing life insurance related services. These comprise of individual assurance, general annuities, pensions, non-linked health, unit linked business, and group insurance businesses. Its product portfolio includes endowment assurance plans, money back plans, term assurance plans, pension plans, special plan, Aam Admi Bima Yojna, unit plans, special plans, health plan and group schemes. LIC operates through its zonal areas located in Mumbai, Delhi, Kolkata, Chennai, Hyderabad, Kanpur, Bhopal, and Patna. The company primarily operates in India. LIC is headquartered in Mumbai, Maharashtra, India.

Scope

- Detailed information on LIC of India required for business and competitor intelligence needs
- A study of the major internal and external factors affecting LIC of India in the form of a SWOT analysis
- An in-depth view of the business model of LIC of India including a breakdown and examination of key business segments
- Intelligence on LIC of India’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about LIC of India, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of LIC of India and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess LIC of India as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on LIC of India’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 4
LIC of India: Company Overview 8
LIC of India: Overview and Key Facts 8
LIC of India: Overview 8
LIC of India: Key Facts 8
LIC of India: Key Employees 9
LIC of India: Key Employee Biographies 11
LIC of India: Major Products and Services 12
LIC of India: Company History 13
LIC of India: Management Statement 15
LIC of India: Locations and Subsidiaries 16
LIC of India: Key Competitors 18
LIC of India: Company Analysis 19
LIC of India: Business Description 19
LIC of India: SWOT Analysis 20
LIC of India: SWOT Overview 20
LIC of India: Strengths 20
LIC of India: Weaknesses 21
LIC of India: Opportunities 21
LIC of India: Threats 22
LIC of India: Corporate Financial Deals Activity 23
LIC of India: Financial Deals Overview 23
LIC of India: Targets and Partners 25
LIC of India: Top Deals 2014 – 2018YTD* 26
LIC of India: Mergers and Acquisitions 27
LIC of India: Corporate Venturing 28
LIC of India: Divestments 29
LIC of India: Recent Developments 30
LIC of India: News and Events Summary 30
LIC of India: Business Expansion 32
LIC of India: Contracts 32
LIC of India: Corporate Governance 33
LIC of India: Corporate Social Responsibility 33
LIC of India: Financial Deals 34
LIC of India: Regulatory and Legal Events 35
LIC of India: Strategy and Operations 35
Appendix 37
Contact Us 37
Methodology 37
About MarketLine 38

List of Tables
Table 1: LIC of India: Key Facts
Table 2: LIC of India: Key Employees
Table 3: LIC of India: Locations and Subsidiaries
Table 4: LIC of India: Key Competitors
Table 5: LIC of India: Deal Activity by Deal Type - Volume (TTM*)
Table 6: LIC of India: M&A Activity by Geography (TTM*)
Table 7: LIC of India: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 8: LIC of India: M&A Average Deal Size - Value (US$m)
Table 9: LIC of India: Targets and Partners
Table 10: LIC of India: Top Deals 2014 - 2018YTD*
Table 11: LIC of India: M&A Volume and Value Trend (2014 - YTD*2018)
Table 12: LIC of India: M&A Activity by Geography (2014 - YTD*2018)
Table 13: LIC of India: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Table 14: LIC of India: Corporate Venturing by Geography (2014 - YTD*2018)
Table 15: LIC of India: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 16: LIC of India: Divestments by Geography (2014 - YTD*2018)
Table 17: LIC of India: News and Events Summary
Table 18: LIC of India: Business Expansion
Table 19: LIC of India: Contracts
Table 20: LIC of India: Corporate Governance
Table 21: LIC of India: Corporate Social Responsibility
Table 22: LIC of India: Financial Deals
Table 23: LIC of India: Regulatory and Legal Events
Table 24: LIC of India: Strategy and Operations

List of Figures
Figure 1: LIC of India: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: LIC of India: M&A Activity by Geography (TTM*)
Figure 3: LIC of India: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 4: LIC of India: M&A Average Deal Size - Value (US$m)
Figure 5: LIC of India: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 6: LIC of India: M&A Activity by Geography (2014 - YTD*2018)
Figure 7: LIC of India: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Figure 8: LIC of India: Corporate Venturing by Geography (2014 - YTD*2018)
Figure 9: LIC of India: Divestments Volume and Value Trend (2014 - YTD*2018)
Figure 10: LIC of India: Divestments by Geography (2014 - YTD*2018)

★海外企業調査レポート[LIC of India：企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Pfizer Inc (PFE)：製薬・医療：M&Aディール及び事業提携情報
    Summary Pfizer Inc (Pfizer) is a biopharmaceutical company, which discovers, develops, manufactures and markets healthcare products. It provides medicines, vaccines and consumer healthcare products. The company provides products to treat various conditions including infection, cancer, inflammation, …
  • DaVita Inc (DVA)：医療機器：M&Aディール及び事業提携情報
    Summary DaVita Inc (DaVita), formerly DaVita HealthCare Partners Inc., is a provider of dialysis services and integrated health care delivery and management services. The company is a provider of dialysis services in the US for patients with chronic kidney failure and end-stage renal disease (ESRD). …
  • CSX Corporation, Inc.：戦略・SWOT・企業財務分析
    CSX Corporation, Inc. - Strategy, SWOT and Corporate Finance Report Summary CSX Corporation, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Nippon Yusen Kabushiki Kaisha (9101)-石油・ガス分野：企業M&A・提携分析
    Summary Nippon Yusen Kabushiki Kaisha (NYK) is a logistics company transporting crude oil and allied products. The company provides ocean, land, and air transport services for the transportation of petroleum products, liquid products and dry bulk products. Its portfolio includes line trade, air carg …
  • CRH Medical Corp (CRH)-医療機器分野：企業M&A・提携分析
    Summary CRH Medical Corp (CRH Medical), formerly Medsurge Medical Products Corp is a medical device company that provides treatment of hemorrhoids. The company provides CRH O’Regan System, a hemorrhoid technology for treating hemorrhoid. It provides topical ointments and creams including preparation …
  • Taiflex Scientific Co., Ltd. (8039)：企業の財務・戦略的SWOT分析
    Taiflex Scientific Co., Ltd. (8039) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • James Fisher and Sons Plc (FSJ)-石油・ガス分野：企業M&A・提携分析
    Summary James Fisher and Sons plc (James Fisher) is a service provider that focuses on global marine industry and a specialist supplier of engineering services to the energy industry. The company provides comprehensive services such as design and engineering; inspection and monitoring; lifting and h …
  • Ferno-Washington Inc：企業の戦略的SWOT分析
    Ferno-Washington Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • GVK Power and Infrastructure Ltd (GVKPIL)：企業の財務・戦略的SWOT分析
    GVK Power and Infrastructure Ltd (GVKPIL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Immunodiagnostic Systems Holdings plc (IDH)：企業の財務・戦略的SWOT分析
    Summary Immunodiagnostic Systems Holdings plc (IDS) is an in-vitro diagnostic solution provider that develops, manufactures and markets immunoassays and automated immunoanalyser technologies. The company conducts research in the areas of bone turnover market, animal research, and other research area …
  • Cogentix Medical Inc (CGNT)：企業の財務・戦略的SWOT分析
    Summary Cogentix Medical Inc (Cogentix Medical), formerly Vision-Sciences Inc, is a medical device company that designs, develops, manufactures and markets fiberoptic and video endoscopy products. The company’s major products include PrimeSight endoscopy systems, Urgent PC neuromodulation system and …
  • 3M Health Information Systems Inc：医療機器：M&Aディール及び事業提携情報
    Summary 3M Health Information Systems Inc (3M HIS), a subsidiary of 3M Co, is a software and consulting services provider. The company offers healthcare technology, software and consulting services. Its services are designed for clinical documentation improvement, computer-assisted coding, mobile ph …
  • Cutera Inc (CUTR)：企業の製品パイプライン分析2018
    Summary Cutera Inc (Cutera) is a medical device company that manufactures, designs, markets, and services medical and aesthetic devices. The company provides laser and energy based aesthetics systems such as pico technology, excel HR technology, excel V technology, Juliet technology, secret RF techn …
  • Wellcome Trust Sanger Institute-製薬・医療分野：企業M&A・提携分析
    Summary Wellcome Trust Sanger Institute (Sanger Institute), a subsidiary of Genome Research Ltd is a genomic discovery and research centre that carries out research and development in the areas of cellular and human genetics and infection genomics. It also provides postgraduate training on research …
  • BioMedomics Inc-医療機器分野：企業M&A・提携分析
    Summary BioMedomics Inc (BioMedomics) is a point-of-care diagnostics company that develops immunologically-based disease-specific tests and advanced highly sensitive quantitative platforms. The company provides technologies such as time-resolved lateral flow immunoassay and nanotube based POC platfo …
  • Sammons Enterprises Inc：戦略・SWOT・企業財務分析
    Sammons Enterprises Inc - Strategy, SWOT and Corporate Finance Report Summary Sammons Enterprises Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Akebia Therapeutics Inc (AKBA)：企業の財務・戦略的SWOT分析
    Summary Akebia Therapeutics Inc (Akebia Therapeutics) is a biopharmaceutical company focused on the development and commercialization of novel therapeutics based on hypoxia inducible factor for patients with kidney disease and other metabolic disorders. Its lead product candidate vadadustat is a HIF …
  • OceanaGold Corporation：企業の戦略・SWOT・財務情報
    OceanaGold Corporation - Strategy, SWOT and Corporate Finance Report Summary OceanaGold Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • ESSA Pharma Inc (EPI)：企業の財務・戦略的SWOT分析
    Summary Essa Pharma Inc (Essa Pharma) is a drug developer that offers oncology therapeutics. The company develops EPI-506, disrupts androgen receptor transcriptional activity through selectively blocking the N-terminal domain of the AR. It also conducts research on prostate cancer and the androgen r …
  • Allianz Global Corporate & Specialty Singapore：企業の戦略・SWOT・財務分析
    Allianz Global Corporate & Specialty Singapore - Strategy, SWOT and Corporate Finance Report Summary Allianz Global Corporate & Specialty Singapore - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, ope …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆